Lebwohl M, Warren RB, Sofen H, Imafuku S, Paul C, Szepietowski JC, Spelman L, Passeron T, Colston E, Hippeli L, Napoli A, Kisa RM, Banerjee S, Menter A, Thaçi D, Blauvelt A. Deucravacitinib long-term efficacy with continuous treatment in plaque psoriasis: 2-year results from the phase 3 POETYK PSO program. J of Skin [Internet]. 2023 Mar. 13 [cited 2024 Jul. 4];7(2):s118. Available from: https://jofskin.org/33014/index.php/skin/article/view/1968